Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beta-d-glucopyranosiduronic Acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl
2. Flavone, 4',5,6,7-tetrahydroxy-, 7-beta-d-glucopyranuronoside
3. Scutellarein 7-beta-d-glucuronide
4. Scutellarein 7-beta-d-glucuronoside
5. Scutellarein 7-glucuronide
6. Scutellarein 7-o-beta-d-glucuronide
7. Scutellarein-7-o-beta-glucuronide
8. Scutellarein-7-o-glucuronide
9. Scutellarin B
1. 27740-01-8
2. Breviscapin
3. Scutellarein-7-glucuronide
4. Scutellarin B
5. Breviscapine
6. Scutellarein-7beta-d-glucuronoside
7. 116122-36-2
8. Scutellarein-7beta-d-glucuronide
9. Scutellarein-7-o-beta-d-glucuronide
10. (2s,3s,4s,5r,6s)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic Acid
11. Scutellarein 7-o-glucuronide
12. Scutellarein 7-o-beta-d-glucuronide
13. 16igp0ml9a
14. Beta-d-glucopyranosiduronic Acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl
15. Chembl487805
16. (2s,3s,4s,5r,6s)-6-((5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic Acid
17. Chebi:61278
18. Scutellarein 7-glucuronide
19. 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl Beta-d-glucopyranosiduronic Acid
20. 7-(beta-d-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
21. 676536-34-8
22. Unii-16igp0ml9a
23. Dengzhanhua
24. Scutellarine
25. New-breviscapine
26. Scutellarin,(s)
27. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic Acid
28. Megxp0_000554
29. Schembl4211849
30. Scutellarin, Analytical Standard
31. Dtxsid101336184
32. S-7-g
33. Bcp11536
34. Flavone, 4',5,6,7-tetrahydroxy-, 7-beta-d-glucopyranuronoside
35. Hy-n0751
36. Bdbm50242284
37. Mfcd01861503
38. S3810
39. Scutellarein Glucuronide [mi]
40. Zinc21992916
41. Akos016009652
42. Ac-6073
43. Ccg-269364
44. Ccg-269365
45. Cs-4273
46. Ncgc00480778-01
47. Scutellarein Glucuronide [who-dd]
48. Bs-16838
49. Scutellarein 7-.beta.-d-glucuronide
50. Scutellarein 7-o-.beta.-glucuronide
51. N1753
52. Scutellarein 7-.beta.-d-glucuronoside
53. Scutellarein 7-o-.beta.-d-glucuronide
54. 740s018
55. A819175
56. Q410712
57. Breviscapin;scutellarein-7-glucuronide;scutellarin B
58. Q-100351
59. Flavone, 4',5,6,7-tetrahydroxy-, 7-.beta.-d-glucopyranuronoside
60. (2s,3s,4s,5r,6s)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7- Yl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic Acid
61. (2s,3s,4s,5r,6s)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic Acid
62. (2s,3s,4s,5r,6s)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic Acid
63. .beta.-d-glucopyranosiduronic Acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl
64. 4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-
65. Glucopyranosiduronic Acid, 5,6-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl, .beta.-d-
66. Glucopyranosiduronic Acid, 5,6-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl, Beta-d-
| Molecular Weight | 462.4 g/mol |
|---|---|
| Molecular Formula | C21H18O12 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 4 |
| Exact Mass | 462.07982601 g/mol |
| Monoisotopic Mass | 462.07982601 g/mol |
| Topological Polar Surface Area | 203 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 777 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
67
PharmaCompass offers a list of Breviscapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Breviscapine manufacturer or Breviscapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Breviscapine manufacturer or Breviscapine supplier.
PharmaCompass also assists you with knowing the Breviscapine API Price utilized in the formulation of products. Breviscapine API Price is not always fixed or binding as the Breviscapine Price is obtained through a variety of data sources. The Breviscapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Breviscapine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Breviscapine, including repackagers and relabelers. The FDA regulates Breviscapine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Breviscapine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Breviscapine supplier is an individual or a company that provides Breviscapine active pharmaceutical ingredient (API) or Breviscapine finished formulations upon request. The Breviscapine suppliers may include Breviscapine API manufacturers, exporters, distributors and traders.
Breviscapine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Breviscapine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Breviscapine GMP manufacturer or Breviscapine GMP API supplier for your needs.
A Breviscapine CoA (Certificate of Analysis) is a formal document that attests to Breviscapine's compliance with Breviscapine specifications and serves as a tool for batch-level quality control.
Breviscapine CoA mostly includes findings from lab analyses of a specific batch. For each Breviscapine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Breviscapine may be tested according to a variety of international standards, such as European Pharmacopoeia (Breviscapine EP), Breviscapine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Breviscapine USP).
